IIQ
Inoviq Ltd
- Announcements, last 12 months
- 40
- Price sensitive, last 12 months
- 14
- Followed on InvestorPA
- Low (Outside the 20% most-followed companies on InvestorPA)
Upcoming events
| INOVIQ LIMITED ACN 009 070 384 Annual General Meeting |
Latest announcements
| Released | Headline | Actions |
|---|---|---|
| Notice of Annual General Meeting/Proxy Form | ||
| INOVIQ Announces Leadership Change Price sensitive | AI summary | |
| EXO-OC Technical Review and Commercialisation Pathway Price sensitive | AI summary | |
| 2026 Annual Report | ||
| Appendix 4G and Corporate Governance Statement | ||
| Appendix 4E and Preliminary Financial Report Price sensitive | AI summary | |
| Becoming a substantial holder | ||
| Change of Director's Interest Notice | ||
| EXO-OC Study Outcome Investor Webinar Presentation Price sensitive | AI summary | |
| Quarterly Activities Report and Appendix 4C - June 2026 Price sensitive | AI summary |
Sign in to see all IIQ announcements.
Guidance history
| 27 Aug 2026 | FY26 revenue: $432,047, Net loss: $7,505,123, Cash: $9.4 million | |
| 14 Jul 2026 | INOVIQ aims to minimize impact on development and commercialization timelines for EXO-OC | |
| 13 Jul 2026 | Inoviq Ltd has A$9.353m cash at 30 June 2026, with FY26 project spend totaling A$1.216m. |
Sign in to see the full guidance history.
Most followed in Health Care
Follow IIQ to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in